INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,301,118 | +35.2% | 407,965 | +13.0% | 0.00% | 0.0% |
| Q2 2023 | $7,618,324 | +52.5% | 361,058 | +23.3% | 0.00% | 0.0% |
| Q1 2023 | $4,995,000 | +64004.2% | 292,889 | -24.9% | 0.00% | 0.0% |
| Q4 2022 | $7,792 | -99.9% | 389,999 | +50.9% | 0.00% | 0.0% |
| Q3 2022 | $5,568,000 | -22.9% | 258,524 | -29.4% | 0.00% | 0.0% |
| Q2 2022 | $7,223,000 | +175.1% | 366,244 | +227.9% | 0.00% | – |
| Q1 2022 | $2,626,000 | +0.5% | 111,702 | +16.4% | 0.00% | – |
| Q4 2021 | $2,613,000 | -52.0% | 95,928 | -51.5% | 0.00% | -100.0% |
| Q3 2021 | $5,444,000 | -6.4% | 197,689 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $5,818,000 | -2.0% | 204,429 | +17.3% | 0.00% | 0.0% |
| Q1 2021 | $5,934,000 | +3.6% | 174,213 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $5,730,000 | +0.4% | 172,133 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $5,706,000 | +13.2% | 174,190 | -4.8% | 0.00% | 0.0% |
| Q2 2020 | $5,039,000 | +61.0% | 182,977 | -6.3% | 0.00% | 0.0% |
| Q1 2020 | $3,129,000 | -62.0% | 195,211 | -43.4% | 0.00% | -50.0% |
| Q4 2019 | $8,234,000 | +93.4% | 344,797 | +42.9% | 0.00% | +100.0% |
| Q3 2019 | $4,257,000 | -63.6% | 241,330 | -47.8% | 0.00% | -50.0% |
| Q2 2019 | $11,686,000 | +80.0% | 461,947 | +106.9% | 0.00% | +100.0% |
| Q1 2019 | $6,492,000 | +121.6% | 223,312 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,929,000 | -71.4% | 223,239 | -55.9% | 0.00% | -50.0% |
| Q3 2018 | $10,240,000 | +63.7% | 506,391 | +91.5% | 0.00% | +100.0% |
| Q2 2018 | $6,255,000 | +26.9% | 264,470 | +20.9% | 0.00% | 0.0% |
| Q1 2018 | $4,928,000 | -23.7% | 218,794 | +5.6% | 0.00% | 0.0% |
| Q4 2017 | $6,461,000 | -53.1% | 207,190 | -54.0% | 0.00% | -66.7% |
| Q3 2017 | $13,782,000 | -19.5% | 450,401 | -54.9% | 0.00% | -25.0% |
| Q2 2017 | $17,129,000 | -33.4% | 998,178 | -32.1% | 0.00% | -33.3% |
| Q1 2017 | $25,725,000 | +24.2% | 1,469,167 | -6.1% | 0.01% | +20.0% |
| Q4 2016 | $20,707,000 | -10.8% | 1,565,157 | -2.1% | 0.01% | -16.7% |
| Q3 2016 | $23,213,000 | +19.2% | 1,598,635 | -19.0% | 0.01% | +20.0% |
| Q2 2016 | $19,467,000 | -26.3% | 1,974,261 | -5.3% | 0.01% | -28.6% |
| Q1 2016 | $26,410,000 | -33.4% | 2,084,507 | -4.5% | 0.01% | -30.0% |
| Q4 2015 | $39,635,000 | +1.7% | 2,183,772 | +4.1% | 0.01% | 0.0% |
| Q3 2015 | $38,959,000 | -24.6% | 2,097,972 | -0.8% | 0.01% | -16.7% |
| Q2 2015 | $51,659,000 | +20.2% | 2,115,370 | +2.4% | 0.01% | +20.0% |
| Q1 2015 | $42,969,000 | +45.8% | 2,065,789 | +8.5% | 0.01% | +42.9% |
| Q4 2014 | $29,467,000 | +33.4% | 1,904,739 | +12.5% | 0.01% | +40.0% |
| Q3 2014 | $22,091,000 | -15.4% | 1,692,811 | +29.5% | 0.01% | -28.6% |
| Q2 2014 | $26,113,000 | +46.6% | 1,306,965 | +39.7% | 0.01% | +40.0% |
| Q1 2014 | $17,818,000 | -20.3% | 935,801 | -28.8% | 0.01% | -16.7% |
| Q4 2013 | $22,353,000 | -8.7% | 1,314,839 | -16.2% | 0.01% | -14.3% |
| Q3 2013 | $24,482,000 | +513.0% | 1,568,318 | +369.7% | 0.01% | +600.0% |
| Q2 2013 | $3,994,000 | – | 333,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |